PA
IPI icon

PharVision Advisers’s Intrepid Potash IPI Stock Holding History

PharVision Advisers’s Portfolio IPI Stock Details IPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,286
Closed -$260K – 724
2025
Q2 		$260K Buy
+7,286
New +$248K 0.37% 120

Other funds holding IPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
GRA
Goehring & Rozencwajg Associates New York $1.86B AUM 130.26% 1-Year Est. Return

PharVision Advisers's IPI Position: Q3 2025 in Review

PharVision Advisers sold out of Intrepid Potash (IPI) in Q3 2025, closing a stake of 7,286 shares — an estimated $260K sold.

PharVision Advisers first reported a position in IPI in Q2 2025 and held it in 1 quarter. The position peaked at $260K in Q2 2025. 144 funds tracked by Wall St. Rank hold IPI as of Q3 2025.

  • PharVision Advisers reported no remaining Intrepid Potash position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 7,286 Intrepid Potash shares in Q3 2025, an estimated $260K.
  • PharVision Advisers first reported a position in Intrepid Potash in Q2 2025 and held it in 1 quarter.
  • PharVision Advisers's Intrepid Potash position peaked at $260K in Q2 2025.
  • 144 funds tracked by Wall St. Rank held Intrepid Potash as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.